Search

Kuldeep Dr Neote

from Charlestown, MA
Age ~62

Kuldeep Neote Phones & Addresses

  • Charlestown, MA
  • Indianapolis, IN
  • Cambridge, MA
  • 15 Rose Ln, East Lyme, CT 06333 (860) 691-0360
  • 9350 Cobblestone Ct, Zionsville, IN 46077 (317) 769-4941
  • New London, CT
  • San Mateo, CA
  • Groton, CT
  • 15 Rose Ln, East Lyme, CT 06333

Work

Position: Technicians and Related Support Occupations

Education

Degree: Associate degree or higher

Emails

Business Records

Name / Title
Company / Classification
Phones & Addresses
Kuldeep Neote
Director
Grace Wong
Biotechnology Research
100 Arlington Rd, Boston, MA 02467
Kuldeep Neote
K&S GROUP, LLC
9350 Cobblestone Ct, Zionsville, IN 46077
Kuldeep Neote
STAR GROUP, LLC
15 Rose Ln, East Lyme, CT 06333

Publications

Us Patents

Methods For The Identification Of Compounds Useful For The Treatment Of Disease States Medicated By Prostaglandin D2

View page
US Patent:
20020022218, Feb 21, 2002
Filed:
Apr 11, 2001
Appl. No.:
09/833126
Inventors:
Baiyong Li - Clinton CT, US
Kuldeep Neote - East Lyme CT, US
Ronald Gladue - Stonington CT, US
John Cheng - Waterford CT, US
Paul Bauer - Arlington MA, US
Jiansu Zhang - Rosylndale MA, US
International Classification:
C12Q001/00
C12Q001/68
US Classification:
435/004000, 435/006000
Abstract:
The present invention relates to the discovery that PDGis the nautral ligand for orphan receptor CRTH2, which interaction, it will now immediately be recognized, is important in the development of valuable pharmaceuticals. The present invention is therefore related to methods for screening for therapeutic compounds useful in the treatment of PGD-related disorders such as allergy, asthma and inflammation. Appropriate assay methodology is also disclosed.

Disruption Of The Redk Gene

View page
US Patent:
20030188325, Oct 2, 2003
Filed:
Mar 28, 2003
Appl. No.:
10/402490
Inventors:
William Brissette - Stonington CT, US
John Hambor - Madison CT, US
Kuldeep Neote - East Lyme CT, US
Marsha Roach - Waterford CT, US
Assignee:
Pfizer Inc.
International Classification:
A01K067/027
C12Q001/68
C12N005/08
C12N005/06
US Classification:
800/003000, 800/018000, 435/006000, 435/354000, 435/372000
Abstract:
The invention features non-human mammals and animal cells that contain a targeted disruption of a REDK gene.

Therapeutics And Diagnostics For Disorders Of Erythropoiesis

View page
US Patent:
20040014064, Jan 22, 2004
Filed:
Oct 31, 2002
Appl. No.:
10/285366
Inventors:
William Brissette - Stonington CT, US
Kuldeep Neote - East Lyme CT, US
Panayiotis Zagouras - Old Saybrook CT, US
Martin Zenke - Schoenow, DE
Britt Lemke - Berlin, DE
Christine Hacker - Berlin, DE
International Classification:
C12Q001/68
G01N033/53
G01N033/543
US Classification:
435/006000, 435/007100, 436/518000
Abstract:
The present invention provides novel panels of molecular targets that regulate erythropoiesis. The novel panels of the invention may be used, for example, in therapeutic intervention, therapeutic agent screening, and in diagnostic methods for diseases and/or disorders of erythropoiesis.

Panels Of Molecular Targets Differentially Expressed During Cd8+ T Cell Priming, And Methods For Therapy And Diagnosis Utilizing The Same

View page
US Patent:
20050037369, Feb 17, 2005
Filed:
Oct 31, 2003
Appl. No.:
10/698350
Inventors:
Kuldeep Neote - Zionsville IN, US
Panayiotis Zagouras - Old Saybrook CT, US
Thomas Gajewski - Chicago IL, US
International Classification:
C12Q001/68
G01N033/53
US Classification:
435006000, 435007100
Abstract:
The present invention provides novel panels of molecular targets that are differentially expressed during CD8+ T cell priming. The novel panels of the invention may be used, for example, in therapeutic intervention, therapeutic agent screening, and in diagnostic methods for diseases and/or disorders of the immune system.
Kuldeep Dr Neote from Charlestown, MA, age ~62 Get Report